Hot Pursuit     08-Jul-24
Zydus Lifesciences Ltd spurts 0.43%, up for five straight sessions
Zydus Lifesciences Ltd is quoting at Rs 1167.45, up 0.43% on the day as on 12:44 IST on the NSE. The stock is up 100.73% in last one year as compared to a 25.49% gain in NIFTY and a 48.09% gain in the Nifty Pharma.

Zydus Lifesciences Ltd rose for a fifth straight session today. The stock is quoting at Rs 1167.45, up 0.43% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.14% on the day, quoting at 24289.55. The Sensex is at 79913.8, down 0.1%. Zydus Lifesciences Ltd has added around 7.5% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has added around 2.99% in last one month and is currently quoting at 20453.85, down 0.43% on the day. The volume in the stock stood at 10.23 lakh shares today, compared to the daily average of 16.22 lakh shares in last one month.

The benchmark July futures contract for the stock is quoting at Rs 1169.9, up 0.37% on the day. Zydus Lifesciences Ltd is up 100.73% in last one year as compared to a 25.49% gain in NIFTY and a 48.09% gain in the Nifty Pharma index.

The PE of the stock is 33.92 based on TTM earnings ending March 24.

Previous News
  Indices trade with moderate losses; PSU bank shares decline
 ( Market Commentary - Mid-Session 23-Jul-24   14:31 )
  Market opens on firm note; breadth strong
 ( Market Commentary - Mid-Session 26-Aug-24   09:35 )
  Zydus Lifesciences Ltd drops for fifth straight session
 ( Hot Pursuit - 19-Sep-24   13:35 )
  Stock Alert: Zydus Lifesciences, Dr Reddy’s Lab, Shyam Metalics and Energy, KEC International
 ( Market Commentary - Stock Alert 26-Aug-24   08:31 )
  Zydus Lifesciences Ltd gains for third straight session
 ( Hot Pursuit - 11-Sep-24   13:06 )
  Zydus receives USFDA approval for Valsartan Tablets
 ( Corporate News - 23-Jul-24   15:20 )
  Zydus Lifesciences receives USFDA tentative approval for Diroximel Fumarate Delayed-Release Capsules
 ( Corporate News - 10-Jul-24   16:03 )
  Zydus Lifesciences declare Quarterly Result
 ( Corporate News - 09-May-24   13:52 )
  Zydus Life rises on USFDA nod for heart failure drug
 ( Hot Pursuit - 10-Jul-24   15:36 )
  Zydus announces NDA acceptance of Desidustat in China by NMPA
 ( Corporate News - 23-Apr-24   16:06 )
  Zydus receives USFDA tentative approval for Azilsartan Medoxomil and Chlorthalidone Tablets
 ( Corporate News - 14-Jun-24   13:42 )
Other Stories
  Avantel Q2 PAT jumps 42% YoY to Rs 23 cr
  05-Oct-24   17:03
  Equitas SFB total deposits jump 29% YoY in Q2 FY25
  05-Oct-24   16:28
  Ujjivan SFB total deposits rises 17% in Q2 FY25
  05-Oct-24   15:34
  L&T Finance retail disbursements jump 12% YoY in Q2 FY25
  05-Oct-24   14:31
  Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore
  05-Oct-24   13:32
  Lupin's Pune-based biotech facility gets 5 observations from US FDA
  05-Oct-24   13:20
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
Back Top